Dorsey Brian — SEC Form 4 filings
SEC reporting owner CIK 1380762. 6 Form 4 filings on record with FilingPulse; latest filed 2026-01-05.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-08-15 to 2026-01-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 4 filings — 141,828 shares, $1,823,908 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 50,000 shares @ $15.00 ($750,000) in ARS Pharmaceuticals, Inc., filed 2024-08-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. (SPRY) | Chief Operating Officer | 6 | — | 5 legs · 141,828 sh · $1,823,908 | 12 |
Form 4 filings — Dorsey Brian
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-05 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Grant/award (A): 240,000 (derivative) @ $0 | EDGAR |
| 2025-11-14 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Option exercise (M): 21,828 @ $0.64 · Sale (S): 21,828 @ $8.71 · Option exercise (M): 21,828 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Grant/award (A): 261,900 (derivative) @ $0 | EDGAR |
| 2024-12-13 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Option exercise (M): 15,000 @ $0.64 · Sale (S): 15,000 @ $12.43 · Option exercise (M): 25,000 @ $0.64 · Sale (S): 25,000 @ $12.30 · Option exercise (M): 15,000 (derivative) @ $0 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-08-21 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Option exercise (M): 50,000 @ $0.64 · Sale (S): 50,000 @ $15 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2024-08-15 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Option exercise (M): 30,000 @ $0.64 · Sale (S): 30,000 @ $13 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1380762 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →